Prediction of the skin permeability of topical drugs using in silico and in vitro models.


Journal

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
ISSN: 1879-0720
Titre abrégé: Eur J Pharm Sci
Pays: Netherlands
ID NLM: 9317982

Informations de publication

Date de publication:
01 Aug 2019
Historique:
received: 07 02 2019
revised: 17 05 2019
accepted: 31 05 2019
pubmed: 5 6 2019
medline: 7 1 2020
entrez: 5 6 2019
Statut: ppublish

Résumé

The main challenge of topically applied drugs is to overcome the skin barrier to reach the site of action at the concentration needed for efficacy. In the research of new topical drugs, design of molecules with optimized properties for skin penetration is a key factor and assays for its characterization are needed. A group of 20 representative topical molecules of clinical use were studied in two in silico models (Potts & Guy and Barratt), and an in vitro assay with artificial membrane (Skin-PAMPA). A subset of 9 drugs were also evaluated in the Franz cells assay, formulated in a solvent and in a marketed formulation. Each assay allowed us to grade compounds according to their permeability value. Globally good alignments were found for the studied compounds when comparing models, although discrepancies for some compounds such as tazarotene, tacrolimus, ketoconazole and metronidazole were observed. Overall, the studied in silico and the in vitro models are useful tools to support selection and characterization of research compounds in terms of skin permeability.

Identifiants

pubmed: 31163216
pii: S0928-0987(19)30208-8
doi: 10.1016/j.ejps.2019.05.023
pii:
doi:

Substances chimiques

Membranes, Artificial 0
Pharmaceutical Preparations 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

104945

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Cristina Alonso (C)

Institute of Advanced Chemistry of Catalonia -Spanish National Research Council (IQAC-CSIC) 18-26 Jordi Girona st 08034 Barcelona, Spain. Electronic address: cristina.alonso@iqac.csic.es.

Víctor Carrer (V)

Institute of Advanced Chemistry of Catalonia -Spanish National Research Council (IQAC-CSIC) 18-26 Jordi Girona st 08034 Barcelona, Spain. Electronic address: lcnesl@iqac.csic.es.

Sonia Espinosa (S)

Almirall R&D Center, Ctra. Laureà Miró, 408-410, 08980 Sant Feliu de Llobregat, Barcelona, Spain. Electronic address: sonia.espinosa@almirall.com.

Miriam Zanuy (M)

Almirall R&D Center, Ctra. Laureà Miró, 408-410, 08980 Sant Feliu de Llobregat, Barcelona, Spain. Electronic address: miriam.zanuy@almirall.com.

Mònica Córdoba (M)

Almirall R&D Center, Ctra. Laureà Miró, 408-410, 08980 Sant Feliu de Llobregat, Barcelona, Spain. Electronic address: monica.cordoba@almirall.com.

Bernat Vidal (B)

Almirall R&D Center, Ctra. Laureà Miró, 408-410, 08980 Sant Feliu de Llobregat, Barcelona, Spain. Electronic address: bernat.vidal@almirall.com.

María Domínguez (M)

Almirall R&D Center, Ctra. Laureà Miró, 408-410, 08980 Sant Feliu de Llobregat, Barcelona, Spain.

Núria Godessart (N)

Almirall R&D Center, Ctra. Laureà Miró, 408-410, 08980 Sant Feliu de Llobregat, Barcelona, Spain. Electronic address: nuria.godessart@almirall.com.

Luisa Coderch (L)

Institute of Advanced Chemistry of Catalonia -Spanish National Research Council (IQAC-CSIC) 18-26 Jordi Girona st 08034 Barcelona, Spain. Electronic address: luisa.coderch@iqac.csic.es.

Mercè Pont (M)

Almirall R&D Center, Ctra. Laureà Miró, 408-410, 08980 Sant Feliu de Llobregat, Barcelona, Spain. Electronic address: merce.pont@almirall.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH